Neuroscience

Orexin and the Lateral Hypothalamus

From the National Institutes of Health (NIH):

FOR IMMEDIATE RELEASE
Thursday, August 25, 2005

Researchers Identify a Brain Chemical That Plays a Key Role in Food and Drug-Seeking Behavior

New research performed in rats suggests that orexin, a brain chemical involved in feeding behavior, arousal, and sleep, also plays a role in reward function and drug-seeking behavior.

Dr. Glenda Harris and her colleagues at the University of Pennsylvania showed that the activation of orexin-secreting brain cells in the hypothalamus, a brain region that controls many vital functions such as eating, body temperature, fat metabolism, etc. is strongly correlated with food- and drug-seeking behaviors. Past anatomical studies have shown that these cells in the lateral hypothalamus also project to adjacent reward-associated areas of the brain.

This study suggests that orexin may be a factor in modulating reward-seeking characteristic of substance abuse. The findings help to better identify neural pathways involved in drug abuse, craving and relapse, which may ultimately help scientists find more effective therapies.

This study is published online August 14, 2005 in the journal Nature.

“The brain cells that secrete this substance, orexin, are in an area of the brain called the lateral hypothalamus,” says Dr. Nora D. Volkow, director of the National Institute on Drug Abuse (NIDA), National Institutes of Health, which supported the study. “This brain region has been implicated in reward function for many years, but no one was sure which brain chemicals, or neurotransmitters, were involved. For the first time, we now know exactly which substances are involved, which is a significant step forward in developing treatments.”

[snip]

“We found that the more animals seek out cues associated with food or drug reward, the more activated these neurons become,” says Dr. Harris. In rats that had their drug-seeking behavior extinguished, the preference for drug-associated cues was reinstated by chemically activating these cells and orexin production. These data suggest that this brain system may be involved in the development of drug craving that can perpetuate both addiction and relapse.

“This neural system may be activated by environmental cues that cause addicts to relapse back to drug-taking behavior even after successfully going through rehabilitation and achieving abstinence,” says Dr. Volkow.

[ ... Read the full press release ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain

- Heroin Craving Not Like Thirst For Water
When an addict craves another shot of their chosen drug, how similar is this urge to the basic human drives for sex, food and water? One way scientists have approached this question is to look at the neurocircuitry underlying craving for drugs and compare...

- Embryonic Stem-cell Research
From an NIH press release: Neurons Grown from Embryonic Stem Cells Restore Function in Paralyzed Rats For the first time, researchers have enticed transplants of embryonic stem cell-derived motor neurons in the spinal cord to connect...

- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) And Ms
From the AP, via the New York Times website: FDA Panel Supports MS Drug's Market Return By THE ASSOCIATED PRESS Published: March 8, 2006 Filed at 11:24 a.m. ET WASHINGTON (AP) -- A Food and Drug Administration panel said Wednesday the agency should...

- Af267b And Alzheimer Disease
From medicalnewstoday.com:Experimental Drug Reverses Key Cognitive Deficits, Pathology In Alzheimer's Main Category: Alzheimer's News Article Date: 04 Mar 2006 - 13:00pm (UK) A new drug that enhances the activity of a key brain cell receptor...

- Business World: Takeda's Ramelteon (rozerem, Tak-375)
From the company's press release:Takeda Receives Approval from the Food and Drug Administration for ROZEREM™ (ramelteon) Osaka, Japan, July 23, 2005 - Takeda Pharmaceutical Company Limited (“Takeda”) today announced that its US based global...

Neuroscience